Locations and Appointments
Chronic Lymphocytic Leukemia (CLL)
Insurances Accepted
Please contact the doctor's office to verify that your insurance is accepted.
- AETNA
- Aetna - NYP
- Empire Blue Cross/Blue Shield
- Empire Blue Cross/Blue Shield Healthplus
- GHI
- Health Insurance Plan of NY (HIP)
- Oxford Health Plans
- United Healthcare
- VNSNY CHOICE
About Richard R. Furman, M.D.
Dr. Furman is Director of the CLL Research Center at Weill Cornell Medicine and a member of the Lymphoma/Myeloma Service in the Division of Hematology/Oncology. His area of focus is on the development of non-chemotherapeutic approaches to treating CLL, and has played an integral part in the development of ibrutinib and idelalisib.
For More Videos, please see below:
Lymphoma Cancer Treatment NY - Weill Cornell
Board Certifications
- Hematology
- Internal Medicine
- Medical Oncology
Expertise
Chronic Lymphocytic Leukemia
Hodgkin's Disease
Idiopathic Thrombocytopenic Purpura
Leukemia
Non-Hodgkin's Lymphoma
Waldenstrom's Macroglobulinemia
Education
Fellowship: Mount Sinai School of Medicine
Medical School: Mount Sinai School of Medicine
Residency: Mount Sinai School of Medicine
Languages
- English
Titles & Positions
Associate Attending Physician
Attending Physician
Morton Coleman, M.D. Distinguished Professor of Medicine
Professor of Medicine
Hospital Affiliations
NewYork-Presbyterian / Weill Cornell Medical Center
Education
- Medical School: Mount Sinai School of Medicine
- Fellowship: Mount Sinai School of Medicine
- Residency: Mount Sinai School of Medicine
Titles & Positions
- Associate Attending Physician
- Attending Physician
- Morton Coleman, M.D. Distinguished Professor of Medicine
- Professor of Medicine
Board Certifications
- Hematology
- Internal Medicine
- Medical Oncology
Languages Spoken
- English